MedTrace Logo

The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study

NCT03597087 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 289

Last updated 2018-07-24

No results posted yet for this study

Summary

The investigators compare the recurrence rate difference between two years after transurethral resection of the bladder tumor according to the method of anesthesia. Anesthetic methods are general anesthesia and spinal anesthesia. Assessment of recurrence is assessed by bladder endoscopy, CT, and pathological examination of surgical specimens.

Conditions

Interventions

PROCEDURE

Anesthesia before transurethral resection of the bladder tumor

General anaesthesia or general anesthesia (see spelling differences) is a medically induced coma with loss of protective reflexes, resulting from the administration of one or more general anaesthetic agents. Spinal anaesthesia is a form of regional anaesthesia involving the injection of a local anaesthetic into the subarachnoid space, generally through a fine needle

DRUG

Anesthesia

General anaesthesia : propopol Spinal anaesthesia : bupibacaine

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jin Tae Kim, PhD · Professor, Department of Anesthesiology, Seoul National University Hospital

  • Ja Hyeon Ku, PhD · Professor, Department of Urology, Seoul National University Hospital

  • Hyeong Dong Yuk, MD · Clinical fellow, Department of Urology, Seoul National University Hospital

  • Song Hee Kim, Bacheolor · Researcher, Department of Urology, Seoul National University Hospital

  • Jae Hyun Jung, MD · Clinical fellow, Department of Urology, Seoul National University Hospital

  • Jung Hoon Lee, MD · Clinical fellow, Department of Urology, Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-19
Primary Completion
2021-07-01
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597087 on ClinicalTrials.gov